Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Quantum Materials Corp. (QTMM) Message Board

Scientists in Liverpool mass Covid testing trial d

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 22465
(Total Views: 372)
Posted On: 12/23/2020 5:51:45 PM
Avatar
Posted By: Puravida19
Scientists in Liverpool mass Covid testing trial defend rapid tests
Professor says programme was very helpful, despite criticism about accuracy of lateral flow tests

https://www.theguardian.com/world/2020/dec/23...apid-tests

Excerpt-

Sir John Bell, regius professor of medicine at the University of Oxford, said the lateral flow tests were a “central bit of good defence” against coronavirus because they were “fast, cheap and available for repeat use”, unlike the polymerase chain reaction (PCR) test, which is more accurate but has to be sent to a laboratory, delaying results for days.

As many people got asymptomatic Covid-19 – current government guidance suggests a third of infected people have no symptoms – every case caught by the LFTs in mass testing was a “win”, he said.

The newly published Liverpool data said that lack of access to online information and deprivation were major factors in suppressing testing turnout. A third of the city’s areas were considered deprived, and uptake there was half the average while the number of positive cases was three times higher, said Prof Iain Buchan, executive dean at the Institute of Population Health at the University of Liverpool.

“Fear of not having enough financial support in isolation was the biggest perceived barrier for testing,” he said.

Reflecting on the trial, he said: “The bottom line here is it used a rapid low-cost test that can be carried out anywhere to pick up two-thirds of most infectious people.

“The main conclusion I would draw is trust local communities to self-organise around the smart testing approach. It’s their livelihoods and their lives at stake.”


(0)
(0)




Quantum Materials Corp. (QTMM) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us